Pancreatic Cancer Chemoresistance to Gemcitabine

Pancreatic ductal adenocarcinoma (PDAC), commonly referred to as pancreatic cancer, ranks among the leading causes of cancer-related deaths in the Western world due to disease presentation at an advanced stage, early metastasis and generally a very limited response to chemotherapy or radiotherapy. G...

Descripción completa

Detalles Bibliográficos
Autores principales: Amrutkar, Manoj, Gladhaug, Ivar P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704175/
https://www.ncbi.nlm.nih.gov/pubmed/29144412
http://dx.doi.org/10.3390/cancers9110157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704175/
https://www.ncbi.nlm.nih.gov/pubmed/29144412
http://dx.doi.org/10.3390/cancers9110157

Ejemplares similares